Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: A retrospective analysis of 61 patients with malignant melanoma in American joint committee on cancer stages i and II

Dermatologic Surgery

Volumn 36, Issue 4, 2010, Pages 439-445

  Klode, Joachim ^a   Dissemond, Joachim ^a   Grabbe, Stephan ^a   Hillen, Uwe ^a   Poeppel, Thorsten ^b   Boeing, Carsten ^b  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PATIENT CODING; PRIMARY TUMOR; PRIORITY JOURNAL; REGIONAL METASTASIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURGERY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77950466124     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01479.x     Document Type: Article

References (32)

1. Balch CM. Surgical management of regional lymph nodes in cutaneous melanoma. J Am Acad Dermatol 1980 3 : 511 524.
2. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001 19 : 3622 3634.
3. Gershenwald JE, Thompson W, Mansfield PF, et al. Multiinstitutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999 17 : 976 983.
4. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel node biopsy or nodal observation in melanoma. N Engl J Med 2006 355 : 1307 1317.
5. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001 19 : 3635 3648.
6. Thomas JM. Sentinel lymph node biopsy as the standard of care for cutaneous melanoma. Clin Adv Hematol Oncol 2007 5 : 483 490.
7. Thomas JM. Caution with sentinel node biopsy in cutaneous melanoma. Br J Surg 2006 93 : 129 130.
8. Estourgie SH, Nieweg OE, Kroon BB. High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma. Br J Surg 2004 91 : 1370 1381.
9. van Akkooi AC, Bouwhuis MG, de Wilt JH, et al. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma. Br J Surg 2007 94 : 1293 1299.
10. Kell MR, Ridge JA, Joseph N, Sigurdson ER. PET CT imaging in patients undergoing sentinel node biopsy for melanoma. Eur J Surg Oncol 2007 33 : 911 913.
11. Garbe C, Hauschild A, Volkenandt M, et al. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting. Melanoma Res 2008 18 : 152 160.
12. Wheatley K, Ives N, Hancock B, Gore M. Interferon as adjuvant treatment for melanoma. Lancet 2002 360 : 878.
13. Belhocine T, Pierard G, De Labrassinne M, et al. Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection. Oncologist 2002 7 : 271 278.
14. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992 127 : 392 399.
15. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999 230 : 453 463.
16. Cochran AJ, Balda BR, Starz H, et al. The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 2000 89 : 236 241.
17. Morton DL. Lymphatic mapping and sentinel lymphadenectomy for melanoma: past, present, and future. Ann Surg Oncol 2001 8 : 22S 8S.
18. McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 2001 19 : 2851 2855.
19. Delbeke D. Oncological applications of FDG PET imaging. J Nucl Med 1999 40 : 1706 1715.
20. Delbeke D. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma. J Nucl Med 1999 40 : 591 603.
21. Delbeke D, Martin WH. Positron emission tomography imaging in oncology. Radiol Clin North Am 2001 39 : 883 917.
22. Strauss LG. Sensitivity and specificity of positron emission tomography (PET) for the diagnosis of lymph node metastases. Recent Results Cancer Res 2000 157 : 12 9.
23. Wagner JD, Schauwecker D, Davidson D, et al. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy. J Clin Oncol 1999 17 : 1508 1515.
24. Havenga K, Cobben DC, Oyen WJ, et al. Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma. Eur J Surg Oncol 2003 29 : 662 664.
25. Veit P, Ruehm S, Kuehl H, et al. Lymph node staging with dual-modality PET/ CT: enhancing the diagnostic accuracy in oncology. Eur J Radiol 2006 58 : 383 389.
26. Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer: dual-modality PET/ CT in preoperative staging. Radiology 2003 229 : 526 533.
27. Schoder H, Yeung HW, Gonen M, et al. Head and neck cancer: clinical usefulness and accuracy of PET/ CT image fusion. Radiology 2004 231 : 65 72.
28. Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003 348 : 2500 2507. (Pubitemid 36706537)
29. Antoch G, Saoudi N, Kuehl H, et al. Accuracy of whole body dual modality fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/ CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 2004 22 : 4357 4368.
30. Mijnhout GS, Hoekstra OS, van Tulder MW, et al. Systematic review of the diagnostic accuracy of [18F]fluorodeoxyglucose positron emission tomography in melanoma patients. Cancer 2001 91 : 1530 1542.
31. Wagner JD, Schauwecker DS, Davidson D, et al. FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume. J Surg Oncol 2001 77 : 237 242.
32. Reinhardt MJ, Joe AY, Jaeger U, et al. Diagnostic performance of whole body dual modality 18F-FDG PET/ CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. J Clin Oncol 2006 24 : 1178 1187.